Search Results - "Scharmberg, C."

Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial by Guberina, N, Pöttgen, C, Kebir, S, Lazaridis, L, Scharmberg, C, Lübcke, W, Niessen, M, Guberina, M, Scheffler, B, Jendrossek, V, Jabbarli, R, Pierscianek, D, Sure, U, Schmidt, T, Oster, C, Hau, P, Grosu, A L, Stuschke, M, Glas, M, Nour, Y, Lüdemann, L

“…Glioblastoma is a rapidly proliferating tumor. Patients bear an inferior prognosis with a median survival time of 14-16 months. Proliferation and repopulation…”
Get full text

COSTEP - Comprehensive Suprathermal and Energetic Particle Analyser by Müller-Mellin, R., Kunow, H., Fleißner, V., Pehlke, E., Rode, E., Röschmann, N., Scharmberg, C., Sierks, H., Rusznyak, P., Mckenna-Lawlor, S., Elendt, I., Sequeiros, J., Meziat, D., Sanchez, S., Medina, J., del Peral, L., Witte, M., Marsden, R., Henrion, J.

“…The COSTEP experiment on SOHO forms part of the CEPAC complex of instruments that will perform studies of the suprathermal and energetic particle populations…”
Get full text

The Herschel/Planck programme - technical challenges for two science missions by Heske, A., Passvogel, T., Crone, G., Marti-Canales, J., Scharmberg, C., de Chambure, D., Juillet, J.-J., Collaudin, B.

“…The two science missions Herschel, an observatory-type mission, and Planck, a survey mission, are combined in one program within the long-term science program…”
Get full text